YAP1 has the ability to bind with TEAD and recruit nerves by activating the transcription of the neural growth factor NGF, and research indicates a significant correlation between the occurrence of PNI in prostate cancer and the expression level of YAP1 in tumor tissues (14). Here, YAP1 is linked to prostate carcinoma.